Ticker

Analyst Price Targets — ACRE

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
June 2, 2026 6:21 amMarissa LoboUBS$5.50$4.93StreetInsider UBS Resumes Ares Commercial (ACRE) at Neutral
February 12, 2026 11:54 amDonald FandettiWells Fargo$5.00$5.57TheFly Ares Commercial price target raised to $5 from $4 at Wells Fargo
April 16, 2025 1:12 pmDoug HarterUBS$3.75$3.50TheFly Ares Commercial price target lowered to $3.75 from $5.25 at UBS
September 20, 2024 4:46 amDonald FandettiWells Fargo$7.00$7.81TheFly Ares Commercial downgraded to Underweight from Equal Weight at Wells Fargo
April 25, 2022 8:46 amJ.P. Morgan$16.00$15.58Benzinga JP Morgan Maintains Neutral on Ares Commercial Real, Raises Price Target to $16

Latest News for ACRE

Ares Commercial: High Safety Margin

Ares Commercial faces headwinds from loan losses and office market overexposure, resulting in two dividend cuts in three years. ACRE trades at a steep 50% discount to book value, reflecting investor skepticism about its distributable earnings and portfolio quality. The REIT has shrunk its office loan portfolio by 46% since Q1'23 but still underearns its dividend, with an 80% coverage ratio in Q1'26.

Seeking Alpha • Jul 11, 2026
REITs Are Ready For A Big Comeback: Get Ready To Catch These Dividends

Temporary vacancies and foreclosures crash REIT stock prices, creating a window to buy valuable real estate at a steep discount. Medical Properties Trust has moved past the Steward bankruptcy, with replacement tenants restoring the cash flow pipeline. After defensively shrinking its portfolio, Ares Commercial Real Estate is aggressively leveraging back up (from 1.1x to 1.9x) to drive earnings.

Seeking Alpha • May 17, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for ACRE.

No House trades found for ACRE.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top